EMD-20293
EBOV GPdTM (Mayinga) in complex with rEBOV-548 Fab
EMD-20293
Single-particle17.5 Å
Deposition: 14/06/2019Map released: 22/04/2020
Last modified: 22/04/2020
Sample Organism:
Ebola virus
Sample: EBOV GPdTM (Mayinga) in complex with rEBOV-548 Fab
Deposition Authors: Ward AB, Turner HL, Murin CD
Sample: EBOV GPdTM (Mayinga) in complex with rEBOV-548 Fab
Deposition Authors: Ward AB, Turner HL, Murin CD
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization.
Gilchuk P,
Murin CD,
Milligan JC,
Cross RW 
,
Mire CE,
Ilinykh PA,
Huang K ,
Kuzmina N,
Altman PX,
Hui S ,
Gunn BM,
Bryan AL,
Davidson E,
Doranz BJ,
Turner HL,
Alkutkar T,
Flinko R,
Orlandi C,
Carnahan R,
Nargi R,
Bombardi RG,
Vodzak ME,
Li S,
Okoli A,
Ibeawuchi M,
Ohiaeri B,
Lewis GK,
Alter G,
Bukreyev A,
Saphire EO,
Geisbert TW,
Ward AB,
Crowe Jr JE
(2020) Immunity , 52 , 388 - 403.e12
,
Mire CE,
Ilinykh PA,
Huang K ,
Kuzmina N,
Altman PX,
Hui S ,
Gunn BM,
Bryan AL,
Davidson E,
Doranz BJ,
Turner HL,
Alkutkar T,
Flinko R,
Orlandi C,
Carnahan R,
Nargi R,
Bombardi RG,
Vodzak ME,
Li S,
Okoli A,
Ibeawuchi M,
Ohiaeri B,
Lewis GK,
Alter G,
Bukreyev A,
Saphire EO,
Geisbert TW,
Ward AB,
Crowe Jr JE
(2020) Immunity , 52 , 388 - 403.e12
Grant Support: